The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy (Q43116570)

From Wikidata
Jump to navigation Jump to search
scientific article published on 27 March 2010
edit
Language Label Description Also known as
English
The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy
scientific article published on 27 March 2010

    Statements

    The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit